🔴 ProMIS Neurosciences is trading 7% down in pre-market amid rising yields, oil and geopolitical tensions

ProMIS Neurosciences is trading 6.82% down now at $13.66 after a weak overnight market backdrop and broader risk-off pressure.

• The Nasdaq Composite is down 1.12% and the S&P 500 is down 0.43%; rising Treasury yields, oil prices, and geopolitical tensions are pressuring growth-oriented equities.
• No new company-specific announcement was identified for August 18, 2026.
• The August 13 earnings update was broadly constructive, citing zero ARIA-E cases and cash runway through 2027, so it does not clearly explain the decline.